Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a leading global healthcare company based in China. It focuses on the research, development, manufacturing, and distribution of pharmaceuticals, medical devices, and healthcare services dedicated to improving the quality of life on a global scale.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai Fosun Pharmaceutical (Group) A is scheduled to report its next quarterly earnings on 10/28/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai Fosun Pharmaceutical (Group) A last reported quarterly earnings on 8/25/2026 (Q2 2026). Earnings per share (EPS) came in at 0.32 CNY.
Across its last 3 earnings reports, Shanghai Fosun Pharmaceutical (Group) A stock moved by ±1.9% on average the following day. The largest reaction was +4.3% on 03/24/2026; 2 of 3 reactions were positive.
Shanghai Fosun Pharmaceutical (Group) A has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.